February was a month of twists and turns for the healthcare industry! From the ebb and flow of macro dynamics to the ups and downs of the Q4 reporting season, healthcare stocks experienced a flurry of activity. Meanwhile, the Medtech, Pharma, and Providers space saw a surge of M&A activity. More in this month’s commentary.
Did you know that every 34 seconds a person dies in the United States from cardiovascular disease? It’s the leading cause not only in the US, but also globally.
2023 is underway, and with it has come a sense of excitement. The month of January saw a rotation out of the winners and into the laggards of 2022, driven by hopes of a continued disinflationary trend, the FED temporarily pausing its action, growing confidence in a soft landing, a brighter-than-expected European outlook and recent news that the COVID-19 outbreak in China might have reached its peak. Against this backdrop, healthcare stocks lost -0.7%.